Unveiling the Involvement of Extracellular Vesicles in Breast Cancer's Organotrophic Metastasis: Molecular Mechanisms and Translational Prospects
- PMID: 40564894
- PMCID: PMC12193150
- DOI: 10.3390/ijms26125430
Unveiling the Involvement of Extracellular Vesicles in Breast Cancer's Organotrophic Metastasis: Molecular Mechanisms and Translational Prospects
Abstract
Breast cancer metastasis remains the primary driver of patient mortality, involving dynamic interactions between tumor cells and distant organ microenvironments. In recent years, tumor cell-derived extracellular vesicles (EVs) have emerged as critical information carriers, playing central roles in breast cancer metastasis by mediating organ-specific pre-metastatic niche formation, immune modulation, and tumor cell adaptive evolution. Studies have demonstrated that EVs drive the metastatic cascade through the delivery of bioactive components, including nucleic acids (e.g., miRNAs, circRNAs), proteins (e.g., integrins, metabolic enzymes), and lipids, which collectively regulate osteoclast activation, immune cell polarization, vascular permeability alterations, and extracellular matrix (ECM) remodeling in target organs such as bone, the lungs, and the liver. Molecular heterogeneity in EVs derived from different breast cancer subtypes strongly correlates with organotropism, providing potential biomarkers for metastasis prediction. Leveraging the organotrophic mechanisms of EVs and their dual regulatory roles in metastasis (pro-metastatic and anti-metastatic), strategies targeting EV biogenesis, cargo loading, or delivery exhibits translational potential in diagnostics and therapeutics. In this review, we summarize recent advances in understanding the role of breast cancer-derived exosomes in mediating metastatic organotropism and discuss the potential clinical applications of targeting exosomes as novel diagnostic and therapeutic strategies for breast cancer.
Keywords: breast cancer; breast cancer biomarkers; extracellular vesicles; metastasis.
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
"Small extracellular vesicles: messengers at the service of breast cancer agenda in the primary and distant microenvironments".J Exp Clin Cancer Res. 2025 Jul 21;44(1):216. doi: 10.1186/s13046-025-03471-y. J Exp Clin Cancer Res. 2025. PMID: 40691627 Free PMC article. Review.
-
Small extracellular vesicles and particles (sEVPs) derived from tumor-free pre-metastatic organs promote breast cancer metastasis and support organotropism.Mol Cancer. 2025 Mar 8;24(1):72. doi: 10.1186/s12943-025-02235-8. Mol Cancer. 2025. PMID: 40057730 Free PMC article.
-
Extracellular vesicles: the "Trojan Horse" within breast cancer host microenvironments.Mol Cancer. 2025 Jun 23;24(1):183. doi: 10.1186/s12943-025-02358-y. Mol Cancer. 2025. PMID: 40551109 Free PMC article. Review.
-
Biogenesis and functional implications of extracellular vesicles in cancer metastasis.Clin Transl Oncol. 2025 Jul;27(7):2913-2935. doi: 10.1007/s12094-024-03815-8. Epub 2024 Dec 20. Clin Transl Oncol. 2025. PMID: 39704958 Review.
-
Beyond boundaries: exploring the role of extracellular vesicles in organ-specific metastasis in solid tumors.Front Immunol. 2025 Jun 12;16:1593834. doi: 10.3389/fimmu.2025.1593834. eCollection 2025. Front Immunol. 2025. PMID: 40574836 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical